Archive · 19 Dec 2025
64 Drug Samples Found Not of Standard Quality in November
In November 2025, the central and state drug testing labs in India found that 64 drug samples were not up to the standard quality.
Additionally, 141 more samples were found to be not of standard quality by state labs.
Two drugs from Ghaziabad were found to be fake, made by unauthorized companies using another company's brand name.
The government is investigating and will take action to remove these bad drugs from the market.
This check happens every month to keep our medicines safe.
Central drugs laboratories found 64 drug samples to be not of standard quality (NSQ) in November 2025.
State drugs testing laboratories identified 141 drug samples as NSQ in the same month.
Two drug samples from Ghaziabad were found to be spurious, manufactured by unauthorized companies.
The matter is under investigation, and action will be taken as per the Act and Rules.
This is a routine regulatory activity conducted monthly to ensure drug quality and safety.
- Who
- Central Drugs Laboratories and State Drugs Testing Laboratories
- What
- Identified 64 drug samples as not of standard quality (NSQ) and 2 as spurious
- When
- November 2025
- Where
- India (Central and State Labs), specifically Ghaziabad for spurious samples
- Why
- Routine regulatory surveillance to ensure drug quality and safety
- Number of NSQ samples (Central Labs)
- 64
- Number of NSQ samples (State Labs)
- 141
- Number of spurious samples
- 2
- Location of spurious samples
- Ghaziabad, North Zone
- Action taken
- Investigation and removal from market
- Frequency of checks
- Monthly
- Regulatory body
- Central Drugs Standard Control Organisation (CDSCO)